H.Res. 1285 explained · 119th Congress · Pending in Congress
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Cosponsors: 54 (54 D, 0 R) · per Congress.gov, 2026-10-08
Introduced: 2026-05-14
Latest action (2026-05-14): Referred to the House Committee on Energy and Commerce.
What H.Res. 1285 does, in plain terms
The Congressional Research Service has not published a summary of H.Res. 1285 yet. Its official title: “Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.”.
Constitution Index
“VFA Constitution grade”
Not graded yet
H.Res. 1285 has not been graded yet. New measures with an official summary are graded daily under the published rubric.
What should pass
“VFA SI Solution”
No solution yet
A sourced SI draft appears here once it passes automated checks (Constitution citation, source verification, independent SI critic). How publication works.
For journalists and bloggers
“Embed this grade”
Free to use with the link back. The badge and card update when the grade changes. Embed terms →
